Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Farolfi

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?Delia De Lisi, Ugo De Giorgi, Cristian Lolli, et al.
Oncology Letters|December 2, 2015
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature reviewAlberto Farolfi, Cristiano Ferrario, Michele Aquilina, et al.
Cancers|December 11, 2019
The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer TreatmentNicole Brighi, Alberto Farolfi, Vincenza Conteduca, et al.
Medical Hypotheses|August 21, 2018
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodiesLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Melanoma Research|April 21, 2012
Ipilimumab in advanced melanoma: reports of long-lasting responsesAlberto Farolfi, Laura Ridolfi, Massimo Guidoboni, et al.
BMC Cancer|November 2, 2014
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?Alberto Farolfi, Elisa Carretta, Corradina Della Luna, et al.
Cancers|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or EnzalutamideVincenza Conteduca, Chiara Casadei, Emanuela Scarpi, et al.
Free Radical Biology & Medicine|October 18, 2015
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell culturesDaniela Giustarini, Federico Galvagni, Anna Tesei, et al.
Frontiers in Oncology|April 1, 2022
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical PracticeAlberto Farolfi, Amelia Altavilla, Luca Morandi, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapyAndrea Rocca, Daniele Andreis, Anna Fedeli, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?Delia De Lisi, Ugo De Giorgi, Cristian Lolli, et al.
Oncology Letters|December 2, 2015
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature reviewAlberto Farolfi, Cristiano Ferrario, Michele Aquilina, et al.
Cancers|December 11, 2019
The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer TreatmentNicole Brighi, Alberto Farolfi, Vincenza Conteduca, et al.
Medical Hypotheses|August 21, 2018
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodiesLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Melanoma Research|April 21, 2012
Ipilimumab in advanced melanoma: reports of long-lasting responsesAlberto Farolfi, Laura Ridolfi, Massimo Guidoboni, et al.
BMC Cancer|November 2, 2014
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?Alberto Farolfi, Elisa Carretta, Corradina Della Luna, et al.
Cancers|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or EnzalutamideVincenza Conteduca, Chiara Casadei, Emanuela Scarpi, et al.
Free Radical Biology & Medicine|October 18, 2015
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell culturesDaniela Giustarini, Federico Galvagni, Anna Tesei, et al.
Frontiers in Oncology|April 1, 2022
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical PracticeAlberto Farolfi, Amelia Altavilla, Luca Morandi, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapyAndrea Rocca, Daniele Andreis, Anna Fedeli, et al.
Pageof 7